Deal watch: Biogen acquires Stromedix to pursue novel fibrosis therapy.Published in:Nature Reviews Drug Discovery, 2012, v. 11, n. 4, p. 260, doi. 10.1038/nrd3708By:Crunkhorn, SarahPublication type:Article
Making Virtual Drug Development a Reality.Published in:Bio-IT World, 2010, v. 9, n. 2, p. 40By:DAVIES, KEVINPublication type:Article
Scarred by disease.Published in:Nature Medicine, 2011, v. 17, n. 1, p. 18, doi. 10.1038/nm0111-18By:Hayden, ThomasPublication type:Article
Stromedix acquisition signals growing interest in fibrosis.Published in:Nature Biotechnology, 2012, v. 30, n. 5, p. 375, doi. 10.1038/nbt0512-375By:Allison, MaloryePublication type:Article